Three people were injured in an accident just after 12:30p.m. Friday in Rush County.The Kansas Highway Patrol reported a 2012 ...
From flexible work options to a "zero-burnout" focus and support for employee diversity, these outstanding firms are scoring ...
Findings from a pair of studies in tough-to-treat hypertension establish Mineralys’ drug as a “derisked, almost-commercial ...
Residents of the Kearsarge Lighting Precinct will have the opportunity to vote on dissolving district at the precinct's ...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Q4 2024 Earnings Call Transcript March 4, 2025 Amylyx Pharmaceuticals, Inc.
The Commission on Judicial Conduct's in-house counsel and a former member of the watchdog say the agency's record year for ...
Management provided guidance of $115 million in U.S. BRIUMVI net revenue for Q1 2025 and reiterated the full-year 2025 target of $525 million. January and February 2025 were noted as the highest ...
In 2022, when then-Chief Judge Janet DiFiore was under the commission’s eye, we urged DiFiore to open up the secret proceedings. She retired and the matter ended. Rivera should set a better ...
Michael DiFiore, Evercore ISI: Inquired about the timeline and design for the subcu pivotal trial. Weiss confirmed a mid-2025 start, with dosing intervals still under review and a potential ...
On Feb. 18, 2025, the U.S. Court of Appeals for the First Circuit adopted the “but for” causality standard for violations of the federal ...
Metsera's GLP-1 peptide has a long half-life, meaning it could be administered once a month. And the company is ready to scale up. There's a new kid on the block when it comes to drug companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results